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We have purified a high molecular weight ribonucle- 
ase (hmRNase)  from  human milk by a two-step column 
chromatographic procedure and characterized the en- 
zyme. The molecular mass of hmRNase is 80 kDa  as 
determined from SDS-polyacrylamide gel electropho- 
resis. The pH optimum  of the enzyme is in the range of 
7.5-8.0, similar to other secretory RNases. hmRNase 
is pyrimidine-specific and cleaves the phosphodiester 
bond 3’ to a pyrimidine residue. It selectively degrades 
the pyrimidine strand in poly(rA):poly(rU) and 
poly(dA):poly(rU) double stranded substrates. The ex- 
tent of degradation for naturally occurring RNAs vary 
in the order tRNA c rRNA < mRNA at low enzyme 
concentrations. hmRNase shows allosteric behavior 
with positive cooperativity in  its reaction on polynu- 
cleotide substrates. The activity of the enzyme is  en- 
hanced in the presence of monoribonucleotides. Anti- 
serum obtained against purified hmRNase did not 
cross-react  with low molecular weight RNase which is 
also present in milk. In addition, an immunologically 
cross-reacting species could not be detected in the 
serum, suggesting the origin of hmRNase in the mam- 
mary gland but  not  blood. 
Multiple RNase  activities have been  reported from  several 
body fluids of mammals (1-4). The complete or  partial  se- 
quence information on human RNases currently available 
suggests two predominant categories. The  first category is  the 
pancreatic  RNase-like enzyme, which is also present  in  hu- 
man  urine  and kidney (5-7). The second type is the  nonsecre- 
tory RNase from urine (8) which shares NH2-terminal se- 
quence  identity with RNase from human kidney, liver, and 
erythrocytes (7,  9, 10). 
The ubiquitous  presence of RNases  in body fluids has made 
i t  difficult to assign a precise  role for  these enzymes. However, 
for RNase activity in milk, a protective role in retroviral 
infection  has been envisaged. It was demonstrated  that milk 
RNase  inhibited  the reverse transcription of the  RNA genome 
of mouse mammary tumor virus (11). This observation is 
significant, because mouse mammary tumor virus is trans- 
mitted  through milk from  mother  to progeny in several strains 
of mice (12,13). It  was also  shown that  RNA-dependent  DNA 
synthesis by a retrovirus, avian myeloblastosis virus, incu- 
bated  in  human milk plasma was inversely proportional to  
the  amount of ribonuclease present  in the milk samples (14). 
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These  studies suggested that  the decrease in  RNA-dependent 
DNA  synthesis was due to  degradation of the  RNA genome. 
Furthermore,  the levels of RNase  present  in milk samples 
from donors belonging to  the  Parsi  community were found to 
be lower compared to  those  in milk samples from other  ethnic 
groups (14). Parsis  constitute a highly consanguineous com- 
munity in Western  India  and have about  three  times higher 
age-adjusted  incidence of mammary cancer  compared to  that 
in other Indian communities (15, 16). Jussawala et. al (15) 
have also reported  that  among  Parsi women, breast  cancer 
accounted for 40% of all malignancies. There was thus an 
indication for an inverse correlation between mammary  tumor 
incidence and  the  amount of RNase  activity found in  the milk 
plasma (14). It was therefore of interest  to  study  the  RNase 
activity  present  in  human milk. 
Recently, RNases have been recognized to constitute a 
superfamily,  in  which  several  diverse proteins  such as angi- 
ogenin and eosinophil cationic protein are shown to share 
sequence homology with ribonucleases (17-19). These pro- 
teins possess  ribonuclease activity  in  addition  to  other diverse 
functions (18, 20-22). In  addition, a neurotoxin isolated  from 
the  granules of an eosinophil named eosinophil-derived neu- 
rotoxin was shown to have  ribonuclease activity (21) and  has 
a sequence identical  to  human  nonsecretory ribonuclease (23). 
In  an  earlier  paper  the high  molecular  weight  ribonuclease 
from human milk (hmRNase)’ was shown to be an isoform of 
lactoferrin, an 80-kDa glycoprotein present in milk with a 
major role in iron storage and transport (see “Discussion”) 
(24). In  this  paper, we report purification of the high  molecular 
weight  ribonuclease  from human milk and  its enzymatic char- 
acterization. 
EXPERIMENTAL  PROCEDURES 
Materials-[’HIUridine and [’Hlorotic acid were obtained from 
Bhabha Atomic Research Centre, India. Agarose-5’-(4-aminophen- 
ylphosphory1)uridine 2’-(3‘)-phosphate, poly(rG), and poly(rU) were 
obtained from P-L Biochemicals. RNA  used  for activity staining of 
gels  was obtained from Calbiochem, phosphocellulose P11 was  from 
Whatman. Uranyl acetate was purchased from Fisher. Polyetheleni- 
mine cellulose sheets impregnated with fluorescent dye were pur- 
chased from Fluka AG. Peroxidase-conjugated anti-rat  (rabbit)  anti- 
body  was purchased from Miles-Yeda. GMP and  dGMP were obtained 
from Nutritional Biochemicals. All other  tine biochemicals, including 
di- andpolynucleotides used in the present experiments were obtained 
from  Sigma. 
Milk  Samples-Milk  was obtained from volunteers at local hospi- 
tals 3-10 days post partum, brought to  the laboratory in an ice bath, 
and stored at  -20 “C. The samples were thawed just before use, 
centrifuged at 100,000 X g for 1 h at 4 “C, and  the pellet and the fat 
button were discarded. The clear middle layer of plasma was  dialyzed 
in 100 volumes of buffer containing 0.01 M sodium phosphate (pH 
6.5), 0.05 M NaCl, and 1 mM PMSF. 
’The abbreviations used are: hmRNase, high molecular weight 
ribonuclease from human milk; PMSF, phenylmethylsulfonyl fluo- 
ride; PAGE, polyacrylamide gel electrophoresis. 
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Isolation of RNA-Escherichia  coli  was cultured in the presence of 
2 mCi of ["]uridine (41 mCi/mmol) per liter, harvested in mid  log 
phase, and labeled RNA was isolated according to the procedure 
described by Midgley (51). Tritiated  rat liver RNA  was obtained by 
injecting rats intraperitoneally with 2 mCi  of [3H]orotic acid (41 mCi/ 
mmol). The  rats were starved for 24 h, and their livers were homog- 
enized in 5 volumes (w/v) of buffer containing 0.05 M Tris-HCI (pH 
7.51, 0.025 M KCI,  0.005 M MgCI2, and 0.25 M sucrose. The homoge- 
nate was centrifuged at 12,000 X g for 15 min at  4 "C. The upper two- 
thirds portion of the  supernatant was mixed with 1/20th volume of 
freshly prepared 10% (w/v) sodium deoxycholate and centrifuged a t  
105,000 X g for 90 min at  4 "C. Transfer RNA was isolated from the 
supernatant,  and rRNA from the ribosome pellet was suspended in 
25 ml of buffer containing 0.025 M sodium acetate  (pH 5.1), 0.15 M 
NaCI, 0.005 M MgCI2, 0.001 M EDTA, and 0.5% w/v bentonite, by 
the phenol extraction method described by Midgley (51). Poly(A') 
RNA was isolated from rat liver according to  the procedure of Skup 
et. a1 (52), and avian myeloblastosis virus RNA was isolated as 
described by Das and Mink (53). 
Before using as a substrate for RNase, RNA preparations were 
routinely checked for purity and integrity by electrophoresis on a 
2.5% polyacrylamide gel (23 X 10 cm) cast in the buffer, 0.036 M Tris, 
0.03 M sodium phosphate (pH 7.8), and 0.001 M EDTA (Tris-phos- 
phate buffer). Electrophoresis was carried out in the same buffer a t  
40 mA for 3 h, and  the RNA bands were detected by staining with 
0.2% (w/v) Methylene Blue. 
RNase Assay  Using 3H-Labeled Substrates-The standard reaction 
mixture contained 0.01 M Tris-HCI (pH 7.5), 0.05 M NACI,  40  pg  of 
"H-labeled RNA (1000 cpmlpg RNA) and  an aliquot of the enzyme 
in a final volume of 50 pl. Incubations were done for 15 min (or as 
mentioned in the individual legends to the figures) a t  37 "C. An 
aliquot  (25 pl)  of reaction mixture was spotted on a  2 X 10-cm strip 
of Whatman No. 3 chromatography paper  pre-streaked with glacial 
acetic acid. The strip was chromatographed in a solvent system 
containing 95% ethanol and 1 M ammonium acetate (l:l, v/v). The 
strip was dried, the origin was cut out, and  the amount of undegraded 
RNA was determined by measuring the radioactivity present at  the 
origin of the  strip (54). One unit of RNase was defined as  the enzyme 
needed for degradation of 1 pg of E. coli [3H]RNA in 15 min under 
the assay conditions mentioned above. 
Assay of RNase Using  Unlabeled Substrates-The activity of RNase 
on unlabeled substrate was measured by a modification of the pro- 
cedure described by Kalnitsky et. al (55). The enzyme was incubated 
with 50 A ~ M )  units of the  substrate a t  37  "C in 0.01 M Tris-HCI (pH 
7.4) containing 0.05 M NaCI. The undegraded substrate was precipi- 
tated by incubation with an equal volume of a solution containing 
0.5% (w/v) uranyl acetate and 16% (w/v) perchloric acid. The mixture 
was chilled in an ice bath for 30 min, centrifuged at  10,000 X g for 15 
. min. The absorbance (A2m) of the  supernatant was determined for 
quantitating the activity. With poly(rC) and poly(rA):poly(rU) as 
substrates, hyperchromicity assay described by Kalnitsky  et al. (55) 
was used.  Double stranded substrates poly(rA):poly(rU) and 
poly(dA):poly(rU) were freshly annealed before use, and  their double 
strandedness was confirmed by melting curves. 
Analysis of the Degradation Products of Dinucleotides-The dinu- 
cleotides CpG or GpC  were incubated with hmRNase,  RNase A, or 
phosphodiesterase in 10 pl of 0.01 M Tris-HCI (pH 7.5) a t  37  "C for 
30 min. Each of the assay mixtures was spotted  on  a polyethelenimine 
cellulose sheet impregnated with a fluorescent dye, chromatographed 
with distilled water, and  the  spots were observed under UV light. The 
nucleosides migrate with characteristic relative mobilities, and  the 
nucleotides remain at  the origin. The  sheet was dried and rechroma- 
tographed in 0.075 M Tris-HCI (pH 8.0) until the buffer front was 
just below the spot corresponding to guanosine and  the mono- and 
dinucleotides move  from the origin. 
Protein Estimations-Protein concentration was determined ac- 
cording to Lowry  et. a1 (56). 
Gel Electrophoretic Procedures-SDS-PAGE was performed ac- 
cording to Laemmli (57), and  the protein  bands were visualized by 
silver stainingon SDS-PAGE. Glycosylation was tested using periodic 
acid Schiffs reagent. Isoelectric focusing was done according to  the 
method describ.td by O'Farell (58). 
Staining of the gels after  SDS-PAGE for the detection of RNase 
activity (zymogram of RNase) was carried out  as follows: The gel was 
fixed in 25% isopropanol buffered with 10 mM Tris-HCI (pH 7.5) for 
2  h at room temperature. It was then washed free of isopropanol in 
the above buffer and was incubated in a solution containing 2.5 mg/ 
ml RNA at 37 "C for 12 h. The gel was washed in Tris buffer with 
three changes for 30 min each. Staining for RNA was carried out 
using a 0.1% solution of Methylene Blue in distilled water. Continu- 
ous shaking at  75 rpm was maintained throughout the process. 
Appearance of clear bands  in  a  dark blue background after  destaining 
indicated the presence of RNase. 
Amino Acid  Analysis-The amino acid composition was determined 
after hydrolysis of hmRNase in 6 N HCI at  100 "C in uacuo. The 
cysteine content was determined after performic acid oxidation of the 
protein and also by a  spectrophotometric method (59). 
Immunological Procedures-Antisera against purified hmRNase 
were raised by primary and secondary immunizations (0.5 mg each) 
of rats. Antisera were used in Ouchterlony double diffusion analysis 
(60) and for immunoblotting  experiments (61). 
RESULTS 
The zymogram of human milk plasma revealed two bands 
with RNase  activity (Fig. 1, lane I )  corresponding to molec- 
ular masses of 80 and 14 kDa, respectively. RNase with a 
molecular mass as high as 80 kDa as measured under  dena- 
turing conditions has  not been observed so far  in any verte- 
brate body fluids. The 80-kDa enzyme (hmRNase) was puri- 
fied to homogeneity and characterized  further. 
Purification of hmRNase  from Human Milk Plasma-The 
dialyzed milk plasma (50 ml) was adsorbed onto a  phospho- 
cellulose column (1.5 X 30 cm), equilibrated with 10 mM 
sodium phosphate  (pH 6.5), 50 mM NaCl, and 1 mM phenyl- 
methylsulfonyl fluoride (PMSF). After washing the column 
with the same buffer containing 0.2 M NaC1, the adsorbed 
proteins were eluted  with  a  linear  gradient of  0.2-1.5 M NaCl 
(Fig. 2). Two peaks of RNase  activity were obtained, and  the 
fractions  corresponding to  the major peak  eluting at  0.7-1.0 
M NaCl were pooled, concentrated, and dialyzed in  10 mM 
Tris-HC1 (pH 7.5) and 1 mM PMSF  (Tris buffer). The enzyme 
was chromatographed on  an agarose 5'-(4-aminophenylphos- 
phory1)uridine 2'-(3')-phosphate column equilibrated in  Tris 
buffer. The column was washed with the  same buffer, and  the 
enzyme was eluted  with Tris buffer containing 0.5 M NaCl 
(profile not shown). hmRNase  is a major component of the 
proteins present  in  the milk plasma, and  after purification 
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FIG. 1. Zymogram of crude milk plasma. The milk plasma 
was electrophoresed on a 12.5% SDS-PAGE and was washed free of 
SDS in a buffer containing 0.01 M Tris-HC1 (pH 7.5), 0.05 M NaCI, 
25% isopropanol. The gel was incubated in the above buffer contain- 
ing 2.5 mg/ml RNA for 12 h at  37 "C with constant shaking and 
washed with Tris buffer. RNA on the gel was stained with Methylene 
Blue and destained  in distilled water as described under "Experimen- 
tal Procedures." Lane I ,  zymogram; lane 2, gel stained with Coomassie 
Blue to detect total protein. 
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FIG. 2. Elution profile  of hm- 
RNase from phosphocellulose col- 
umn. Milk plasma was adsorbed onto 
the column in 0.01 M sodium phosphate 
(pH 6.5),  0.05 M NaCI, and 0.001 M 
PMSF, washed with the same buffer con- 
taining 0.2 M NaCl. The adsorbed pro- 
teins were eluted with a  gradient of 0.2- 
1.5 M NaCI. RNase activity (0) was as- 
sayed using E. coli [3H]RNA as described 
under “Experimental Procedures.” Pro- 
tein was monitored at  Am (0). 
TABLE I 
Purification of hmRNase 
Aliquots of the milk plasma and pooled fractions containing 
hmRNase were assayed using E. coli [3H]RNA as a substrate, as 
described under  “Experimental Procedures.” 
step protein activity fzvig,” Yield  Purification 
mg units unitslmg 55 -fold 
1. Crude milk plasma 800  21,760 27.2 
2. Phosphocellulose 16.5 16,087 975 81 36 
3. Affinitv column 12.4 14,552 1,173 67 43 
column 
94 K- 
67 K- 
43 K- 
30 K- 
20 K- 
14.4 K- 
3A 38 3C 
1 2 3 4 5  
” -1 
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FIG. 3. SDS-PAGE profiles  of hmRNase. A, SDS-PAGE  pro- 
files of samples from various stages of purification. Electrophoresis 
was carried out in 10% SDS-polyacrylamide gel and was stained by 
the silver staining. Lane I ,  standard molecular weight markers; lane 
2, crude milk plasma; lane 3, phosphocellulose column pooled fraction; 
lane 4, affinity column fraction; lane 5, affinity column fraction loaded 
5-fold greater than in lane 4. B,  zymogram of purified hmRNase. The 
zymogram was obtained under  conditions identical to those described 
in  the legend to Fig. 1. C, Western  blot of the crude milk plasma. Rat 
antiserum raised against purified hmRNase was  used for blotting. 
there is a 43-fold enrichment of the enzyme activity (Table 
I). 
The protein profiles of the crude milk plasma and each of 
the steps of purification are shown  in Fig.  3A. The ribonucle- 
ase purified by this procedure appeared as a single band on 
40 So So roo 120 140 160 
Fraction numbers 
SDS-PAGE (Fig.  3A) or on anodic and cathodic native gels 
(not shown). The hmRNase preparation was free of the 14- 
kDa RNase as seen from the lack of low molecular weight 
band in the zymogram (Fig. 3B) or in Western blot of the 
crude milk plasma using antibodies raised against hmRNase 
(Fig.  3C). When checked  for  enzyme activities such as DNase, 
phosphodiesterase, alkaline phosphatase, or nonspecific es- 
terases, no such activities could  be detected in purified ma- 
terial (results not shown). 
Molecular Weight-From the SDS-PAGE profile  (Fig. 3A) 
the subunit molecular mass of the purified hmRNase was 
found to be 80 kDa. The mobility of the enzyme on SDS- 
PAGE  was not affected by reduction with  /3-mercaptoethanol 
or by boiling (not shown). This band could  also  be detected 
by activity staining of the SDS-polyacrylamide gel (Fig. 323). 
These results suggest that  the enzyme  is  composed of a single 
polypeptide. The positive staining of the RNase band with 
periodic  acid Schiffs  stain indicated the glycoprotein nature 
of hmRNase (not shown). 
Amino  Acid  Analysis-The amino acid composition of 
hmRNase obtained as described under “Experimental Proce- 
dures” is presented in Table 11. Since hmRNase was  proposed 
to be an isoform of lactoferrin, the amino acid composition of 
human lactoferrin and human pancreatic RNase calculated 
from the published sequence (25,  26) are also given  for  com- 
parison. It can be seen that the experimental values for 
hmRNase are in good agreement with that of lactoferrin for 
many amino acids.  However, a few differences exist, such as 
for tryptophan  and cysteine. hmRNase reveals a  rather high 
cysteine content of 8 mol % measured in the form of cysteic 
acid after oxidation of the protein by performic acid, prior to 
hydrolysis. In order to confirm this result, the spectrophoto- 
metric method using titration with 5,5‘-dithiobis-(2-nitroben- 
zoic acid) was carried out for the determination of cysteine. 
The free sulfhydryl groups estimated with  unreduced protein 
was  very  low  (0.3  mol %), whereas after reduction with dithi- 
othreitol it showed a value of about 9 mol % which is in 
accordance with the cysteine content estimated after per- 
formic  acid oxidation. 
Thermal Stability-On heating the hmRNase, 60% of the 
activity with E. coli t3H]RNA as  the  substrate under standard 
assay conditions was lost at 60 “C in 5 min,  while at  90 “C, 
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TABLE I1 
Amino acid composition of hmRNase 
Hydrolysis of purified hmRNase was carried  out for 24 and 72 h 
as described under  “Experimental  Procedures.”  Data for valine,  leu- 
cine and isoleucine were from analysis after 72-h digestion. The 
values for other  amino acids were intrapolated  to 0 h and  presented 
in  the table. Data for human  Lactoferrin (25. 26) and  human  Pan- 
creatic  RNase  (5) were derived from published  sequences. 
Mole ’X 
Amino acid 
hmRNase  Lactoferrin p~~~~~ 
Aspartic  a id + asparagine 9.2  53 + 4.5  .7 + 7.0 
~~~ 
Threonine 
Serine 
Glutamic  acid + glutamine 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Trwtouhan 
.~ 
4.8  4.2 6.2 
6.8  7.7 12.5 
4.4 5.8  5.5 
7.0 7.7  3.9 
8.4 8.9 3.1 
7.6“ 4.6  6.2 
8.2 6.9  7.8 
0.8 0.8  3.9 
2.8 2.4  2.3 
7.6 8.1 1.6 
2.3 2.3  3.9 
3.8 4.4  3.1 
1.5 1.2  3.9 
6.1 6.2  6.2 
5.8 6.8  7.8 
3.7b 1.6 
10.5 5.6 + 4.2  4.7 + 5.5 
~ 
“Value obtained after oxidation of protein with performic acid 
‘Determined by spectrophotometric  method. 
prior  to acid hydrolysis. 
TABLE I11 
Effect of different  cations on  the  activity of hmRNase 
Assays were carried  out  with E.  coli [3H]RNA  substrate  as described 
under “Experimental Procedures.” Percentage activity retained by 
the enzyme in  the  presence of various  ions,  calculated with  respect  to 
the activity  observed in  control  without  the added ions  is  presented. 
Cation  Concentration  Activity  remai ing 
mM ’X 
Mgf2 2  95 
5 50 
10 0 
Mn+2 2  2.6 
Ca+2 2 2.0 
Fe+3 1 60.3 
Fe+2 1 0 
cu+2 1 0 
Zn+’ 1 0 
co+2 1 59.9 
85% loss of activity was observed. The enzyme was totally 
inactivated by heating at  90 “C for 10  min. 
pH Profile-The hmRNase was assayed in  HEPES buffer 
(pH range of  6.5-8.5) with E. coli [3H]RNA  as  the  substrate. 
The  enzyme showed a broad  pH  optimum  in  the  range of  7.5- 
8.0 (not shown). pH optimum in the alkaline range is a 
characteristic of the secretory RNases (1). The isoelectric 
point of hmRNase was found to  be 6.8 as judged from  the 
mobility on  an isoelectric focusing gel (not  shown) 
Effects of Different Cations-Various cations were tested 
for  their effect on  hmRNase  (Table 111). Sodium chloride (50 
mM) was found to increase the  activity  to a slight  extent  (and 
hence was routinely used in reaction buffer). However, at  
higher  concentrations of Na+ (above 0.15 M) there was inhi- 
bition of the enzyme activity  (data  not shown). Except for 
Mgz+ all other cations in the 1-2 mM range inhibited the 
activity  tested  on E. coli [3H]RNA. 
Time Course of the Reaction-The reactions of hmRNase 
)nuclease from  Human Milk 
showed  a  lag at  the  initial  time  points with E. coli RNA and 
synthetic ribopolymers as  substrates  (data  not  shown). A  lag 
of 5 min was observed  when 3.5 mg/ml  enzyme was used in a 
reaction with 1 mg/ml substrate.  The  time lag decreased at  
higher concentration of the enzyme (7 mg/ml). To test if 
hmRNase was “activated”  during  incubation,  it was preincu- 
bated at  37 “C for 15 min  in  the  reaction buffer prior  to  the 
addition of RNA. This  did  not abolish the lag, and  the  time 
course at  the two concentrations  tested  remained identical to 
that  without  preincubation  (data  not  shown). 
Effect of Mononucleotides on  hmRNase Activity-Certain 
mononucleotides were tested for their effect on hmRNase 
activity,  since  they  are  either  the  products or product  ana- 
logues during the reaction. Mononucleotides 5’-CMP, 5‘- 
GMP,  dGMP,  ATP,  and  dATP  at a concentration of  0.5 mM 
stimulated  the  reaction 2- to 3-fold. At lower concentration 
of the nucleotides (0.1 mM) there was no  change  in  the level 
of activity  (Table IV). 
Action on  Natural Substrates-Various naturally occurring 
substrates such as rRNA, tRNA, and poly(A+)-RNA were 
tested for their  degradation by hmRNase. All of them were 
degraded equally efficiently at  high concentrations of the 
enzyme (800 pg/ml).  However, at low enzyme concentrations 
(100 pg/ml),  mRNA was degraded to a greater  extent,  and  the 
degradation level decreased in the order: mRNA (50.4%), 
rRNA (36.1%), and tRNA (20.5%). High molecular weight 
avian  myeloblastosis virus  RNA was completely  degraded in 
15 min at  37 “C  (not  shown). 
Action on  Synthetic Homopolymers-hmRNase was found 
to be a  pyrimidine-specific  enzyme. While  the  degradation of 
poly(rC)  and  poly(rU) were 73.5 and 74.6%, respectively, in 
30 min, for poly(rA) and poly(rG) the degradation was 5.3 
and 1.5%, respectively. When  the double stranded  substrate, 
poly(rU)  .poly(rA)  (both  strands labeled separately) was used 
as a substrate  the pyrimidine strand was selectively degraded, 
while the  purine  strand  remained  intact.  Poly(rU)  annealed 
with  poly(dA) was more  susceptible to  degradation compared 
to  poly(rA)  .poly(rU) or single stranded  poly(rU) (Fig. 4).The 
effect of adjacent  purine  and  pyrimidine bases on  the cleavage 
of the  phosphodiester  bond by hmRNase was examined with 
the dinucleotide substrates CpG and GpC. The  products of 
degradation were analyzed by thin-layer  chromatography  as 
described under  “Experimental Procedures.” When distilled 
water was used as  solvent,  spots corresponding to guanosine 
were observed with CpG as substrate with hmRNase and 
RNase A. A spot corresponding to neither guanosine nor 
cytosine was observed with GpC as  substrate. TO test if GpC 
was not degraded or inactivated  in  any way, it was reacted 
with crude snake venom phosphodiesterase. This resulted 
predominantly in a spot corresponding to guanosine and a 
TABLE IV 
Effect of mononucleotides on  hmRNase activity 
standard  assay  with E.  coli [3H]RNA  as a substrate  at 37 “C for the 
Assay was carried out in the presence of mononucleotides in a 
given time.  Control was without  any  additional nucleotides. 
% substrate  degraded 
Nucleotides 10 min 20 min 
0.1 mM 0.5 mM 0.1 mM 0.5 mM 
Control 19.5  19.5  48.3  48.3 
5‘ CMP 18.8  66.8  36.8  88.9 
5’ GMP 20.5  64.5 48.1 83.1 
5’ AMP 24.0  26.9  48.3  42.6 
ATP 27.7  65.1  47.2  82.1 
dATP 19.3  66.8 34.1 83.7 
dGMP 32.7  61.5  48.5  81.0 
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FIG. 4. Degradation of pyrimidine  strand  in  different sub- 
strates by hmRNase. RNase assay on poly[:’H]rA.poly(rU) (.), 
poly(rA).poly[”H]rU (01, p ~ l y [ ~ H ] r U  (X), poly(dA).poly[’H]rU (W), 
was carried out as described under “Experimental Procedures.” 
minor spot corresponding to cytosine, perhaps due to the 
contaminating  phosphatases  in  the enzyme preparation. 
When  the  same  sheet was chromatographed  in 0.075 M Tris. 
HCl  (pH 8.0), the  spots  corresponding  to mono- and dinucle- 
otides migrated indicating that material remaining at the 
origin with water as solvent was not due to UV-adsorbing 
contaminants.  These  results  indicate  that  hmRNase cleaved 
3’ to a  pyrimidine and  acted  on CpG to yield Cp  and G similar 
t o  RNaseA,  whereas GpC was resistant  to  degradation  (not 
shown). 
Effect of Substrate Concentration  on hmRNase Activity- 
Different  concentrations of poly(rC), poly(rU), poly(rA). 
poly(rU),  and E. coli RNA were studied  using  different  assay 
conditions as described under “Experimental Procedures.” 
Reactions were carried  out  in  the  linear r nge with  respect to 
the  time of incubation  and  the nzyme concentration for each 
of the substrates. In all these reactions, a t  lower substrate 
concentrations (up to 2.5 pg/ml for poly(rC); 25 pg/ml for 
poly(rU); 5  pg/ml for poly(rA).poly(rU);  and 450 pg/ml for 
E. coli RNA)  the  rate of reaction did  not increase in  proportion 
to  the  substrate  concentration.  Furthermore,  at high substrate 
concentrations a sharp decrease in  the  rate of degradation 
was observed (above 15 pg/ml for poly(rC); 100 pg/ml for 
poly(rU);  10 pg/ml for poly(rA)-poly(rU);  and 4.5 mg/ml  for 
E. coli RNA).  Between these two  ranges, the  rate of reaction 
increased with substrate  concentration  (data  not  shown).  Hill 
plots were obtained for different  substrates  using  data  points 
where no inhibition was observed (excluding the points at 
high  substrate  concentration where the  reaction was inhib- 
ited).  The Hill  coefficients were calculated  for poly(rC), 
poly(rU), poly(rA) .poly(rU),  and E. coli RNA  and  are 3.6,2.5, 
1.2, and 1.3, respectively. 
Absence of Immunological Cross-reactivity with Human 
Serum Proteins-Ouchterlony  double  diffusion analysis was 
performed using antiserum  against  hmRNase  in  the  central 
well and samples of human sera and milk plasma in the 
peripheral wells. Fig. 5 shows no cross-reactivity between 
anti-hmRNase  antibodies  and  the  samples of blood serum. 
This observation  suggests that  the  hmRNase is  immunologi- 
cally distinct from any of the  human  serum  proteins  and is 
/ 
FIG. 5. Ouchterlony double  diffusion  analysis. The Ouchter- 
lony double diffusion was carried out in 1% agar-agar  gel plates. Rat 
antiserum against purified hmRNase was placed in the central well. 
Other samples loaded in peripheral wells are: 1, human milk  plasma; 
2, preimmune rat  serum; 3, 2-fold diluted human serum sample No. 
1; 4, undiluted human serum sample No. 1; 5, 2-fold diluted human 
serum sample No. 2; 6, undiluted human serum sample No. 2. 
produced in  the  mammary  tissues  rather  than being trans- 
ported from blood. 
DISCUSSION 
Identification of a High Molecular Weight Ribonuclease-In 
human milk there are at least two proteins having RNase 
activity; one of them  has a  molecular mass of 80 kDa  and  the 
other  14  kDa (Fig. 1). Earlier, Dalaly et. a1 (27)  described the 
purification of two ribonucleases from human milk with a 
molecular mass of about  14 kDa. I t  is  likely that  these  RNases 
correspond to  the  14-kDa  RNase observed on  the zymogram 
in  this study. Present  investigations are directed  toward  the 
analysis of the 80-kDa ribonuclease (hmRNase). Usually 
RNases observed in  the body fluids range  in  their molecular 
mass from 13.7 kDa for human  urine  RNase  to 45 kDa for 
RNase from human  serum (3, 28-30). However, the  human 
serum  RNase of 45 kDa  was  shown to aggregate, resulting  in 
species up  to 150 kDa in molecular mass (28-30). Liu and 
Owens (31) observed rat milk RNases  eluting  in a broad peak 
on a Sephacryl column, part of which had a molecular mass 
corresponding to  80 kDa. 
The  hmRNase seems to be  distinct from the low molecular 
mass  RNase  present  in milk  plasma. Immunoblotting of pro- 
teins in crude milk plasma with anti-hmRNase polyclonal 
antibodies  did  not recognize the low molecular  mass  enzyme, 
suggesting that  it is not a degradation  product of hmRNase 
(Fig. 3C). 
Substrate Specificity-hmRNase shows a specificity  for py- 
rimidines as indicated by the degradation of poly(rC) and 
poly(rU) by hmRNase and the resistance of poly(rG) and 
poly(rA) homopolymers. It is thus  similar  to  RNase A and 
other secretory RNases present in body fluids (1, 32-34). 
However, unlike  RNase A, hmRNase  acts  on double stranded 
substrates, poly(rA) .poly(rU) and poly(dA) .poly(rU). The 
pyrimidine specificity was maintained  in a double stranded 
substrate like  poly(rA) .poly(rU), where poly(rU) was selec- 
tively  degraded (Fig. 4). I t  is interesting  that poly(rU) present 
in a poly(dA) .poly(rU) complex  was  digested by hmRNase  to 
a significantly  higher  extent compared to poly(rU)  or 
poly(rA)  .poly(rU), which  suggests that  hmRNase degradation 
of pyrimidine  strands  varies for different  structural contexts. 
The cleavage pattern with the synthetic dinucleotide, CpG 
and GpC,  shows that  the  diester  bond 3‘ to a  pyrimidine, but 
not  to a purine is cleaved; a cleavage typical of a phospho- 
transferase  mechanism  as  in  the case of RNase A (32). 
The  structural  features of the  substrates  appear  to  have  an 
effect on  the  hmRNase  activity at low enzyme concentrations. 
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The  extent of degradation was found  to  be  in  the  order  tRNA 
C rRNA < mRNA, a preference probably related to the 
secondary  structure(s) of these RNAs. This difference could 
be due to either binding of RNA to  the enzyme or in the 
subsequent  catalytic  steps following binding. However, at  high 
enzyme  concentrations  all  these  substrates were degraded to 
comparable extents (90%). Some mammalian RNases are 
known to  exhibit  preferences  in  their  action  toward a struc- 
ture  or limited  nucleotide  sequence  such as  for double strand- 
edness (35) or for dinucleotides (36-38) 
Kinetic Behauior-Kinetic studies of hmRNase using 
poly(rU), poly(rA) .poly(rU),  poly(rC),  and E. coli RNA  indi- 
cate a non-Michaelis-Menten behavior. Hill coefficients for 
poly(rC)  and  poly(rU) were 3.6 and 2.5, while for  poly(rA). 
poly(rU)  and E.coli RNA were 1.2 and 1.3, respectively. Non- 
hyperbolic kinetics were also  reported for RNase A (39-41) 
and  the dimeric seminal  RNase (42-44). In  the case of RNase 
A, Walker et al. (39) suggested that a sharp decrease in  the 
initial  rate of reaction observed at  substrate  concentrations 
of 30-50 mM cyclic CMP could be due to  transition  from  one 
enzyme form with low K, to another form with high K,. 
Multiple  interactions of the  substrate  with  the enzyme were 
also suggested to  result  in  the nonhyperbolic kinetics (41-44). 
For RNase A, the interaction of polynucleotides with the 
enzyme was shown to involve a series of 8-9 charged groups. 
The  binding to polynucleotides spanned a  large portion of the 
surface including the cleft of the  catalytic  center (45). In  our 
study where  polynucleotides were employed, it  is difficult to 
dissect the changes caused by multiple interactions of the 
substrate with the enzyme a t  catalytic  site uersw other  non- 
catalytic  sites. 
A nonlinear time course was observed in the hmRNase 
reaction  (data  not  shown). The initial lag followed by  a spurt 
in  the reaction  could be  due  to  one or more of the following 
reasons: (i) initially, the  substrate could be cleaved into large 
products  that would not be detectable  under  our  assay  con- 
ditions;  (ii) self-activation of the enzyme during  incubation 
at 37 "C; (iii)  stimulation of the enzyme by the  product(s) of 
the reaction; (iv) slow decrease in substrate concentration 
leading  to  the  elimination of inhibitory effect at that  substrate 
concentration (assuming substrate inhibition). The second 
possibility seems to be unlikely since preincubation of the 
enzyme at  37 "C in the  reaction buffer prior  to  the  assay  did 
not  eliminate  the lag. On  the  other  hand, a 2-3-fold increase 
in  the  RNase  activity was observed by the  addition of mon- 
onucleotides (at 0.5 mM concentration, see Table IV) which 
are the likely products or their analogs. The first and the 
fourth possibility listed above cannot be ruled out  since  the 
increase  in  the enzyme substrate  ratio reduces the  lag  time. 
Nonlinearity in the  time  course was  also reported for crude 
human  serum  RNase  with  poly(rC) as substrate (46). 
Origin of hmRNase-Whether the milk RNases  are  synthe- 
sized  and secreted by the  mammary gland or  transported  from 
the  blood is  not  yet clear. Bingham  and  Zittle (47) demon- 
strated  that  RNases  from bovine  milk were identical  to bovine 
pancreatic  RNase in chromatographic  properties  and  amino 
acid composition.  Immunological cross-reactivity was  ob- 
served between these  RNases (48) which  suggested the  trans- 
port of bovine milk RNase from blood. However, Liu et. al 
(49) and Liu and Owens (31) have suggested the  mammary 
origin of rat milk RNase, based on a unique  stimulation of 
milk-RNase by Ca2+ in contrast to the serum RNase. In 
immunological studies using anti-hmRNase antibodies, no 
cross-reacting species  could be  detected  in  human  sera (Fig. 
5). Also, the size of the  hmRNase  makes it quite  distinct from 
human serum RNases reported so far. These observations 
would suggest the  site of synthesis of hmRNase  to be mam- 
mary tissues. 
A study  using monoclonal antibodies  obtained  against 
hmRNase  has revealed  some unexpected  findings (24). 
hmRNase shares several physical, chemical, and antigenic 
properties  with  the  major species of lactoferrin, an  80-kDa 
iron-binding glycoprotein found in high concentrations in 
milk (50). The  eight  NHz-terminal  amino acid  residues of the 
hmRNase  are  identical  with  the published  sequence of lacto- 
ferrin (24). However, the  hmRNase differs  from lactoferrin  in 
the possession of potent nuclease activity  and  in  the lack of 
any  significant  iron  binding activity. In  fact,  ferric  and  ferrous 
ions  inhibit  RNase  activity  (Table 111). A comparison of the 
amino acid  composition of hmRNase with that derived  from 
the  published sequences of human  lactoferrin reveals many 
similarities. However, differences are observed for the per- 
centages of cysteine, proline,  arginine, valine, and  tryptophan 
(Table 11). hmRNase  is  quite  distinct  in  amino acid  compo- 
sition from human pancreatic RNase. Further studies are 
underway to  define  the differences between lactoferrin  and 
hmRNase. 
Purification  and  characterization of milk RNase was the 
first  step  in  our  endeavor  to  analyze  the role of milk RNase 
in  mammary tumorigenecity.  Monoclonal antibodies  against 
hmRNase would be useful in  immunohistochemical  staining 
of large numbers of tissue  samples  from  breast  cancer  pa- 
tients. Such a study will provide information on whether 
RNase  expression  correlates  with  mammary tumorigenecity. 
Monoclonal antibodies will also be used  for accurate  quanti- 
tative  and  qualitative  analysis of hmRNase from  individual 
donors  to  continue  our  studies  on  the significance of  low levels 
of RNase activity seen in the milk from Parsi women and 
higher  incidence of mammary  tumors observed in  this com- 
munity (14-16). 
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